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Abstract
Background: P.Re.Val.E. is the most comprehensive comparative evaluation program of healthcare outcomes in
Lazio, an Italian region, and the first Italian study to make health provider performance data available to the public.
The aim of this study is to describe the P.Re.Val.E. and the impact of releasing performance data to the public.
Methods: P.Re.Val.E. included 54 outcome/process indicators encompassing many different clinical areas. Crude
and adjusted rates were estimated for the 2006-2009 period. Multivariate regression models and direct
standardization procedures were used to control for potential confounding due to individual characteristics.
Variable life-adjusted display charts were developed, and 2008-2009 results were compared with those from 2006-
2007.
Results: Results of 54 outcome indicators were published online at http://www.epidemiologia.lazio.it/prevale10/
index.php.
Public disclosure of the indicators’ results caused mixed reactions but finally promoted discussion and refinement
of some indicators.
Based on the P.Re.Val.E. experience, the Italian National Agency for Regional Health Services has launched a
National Outcome Program aimed at systematically comparing outcomes in hospitals and local health units in Italy.
Conclusions: P.Re.Val.E. highlighted aspects of patient care that merit further investigation and monitoring to
improve healthcare services and equity.
Background
Over the last two decades, there has been increasing inter-
est in the development and implementation of outcome
and process indicators. Such indicators encourage
accountability and improvements in the quality of health
care services; they also guide accreditation and health care
planning interventions [1-6]. Public and private organiza-
tions, as well as research projects, have used different indi-
cators for comparative evaluation of the performance of
healthcare providers and professionals. Some have released
their results to the public in the form of web-based reports
that compare hospital quality [7-13].
In Italy, national and regional outcome research pro-
grams have been conducted, but there has been no sys-
tematic comparison of outcomes at the national level.
The Mattoni-Outcome Project, funded by the Italian
Ministry of Health [13], and the subsequent Progr.Es.Si.
Project, have been the main national experiences in this
field. The Mattoni-Outcome Project methodologies were
the starting point for the Regional Outcome Evaluation
Program, called P.Re.Val.E. [14,15], which was conducted
in the Lazio region of Italy (5, 493, 308 residents [16]). P.
Re.Val.E. is the most comprehensive comparative evalua-
tion of regional healthcare outcomes and the only Italian
study to publicly disclose performance data.
The objectives of P.Re.Val.E. were to define and evalu-
ate outcome/process indicators in order to:
￿ compare the outcomes of health care provided by
different hospitals or in different geographical areas
for purposes such as accreditation, remuneration,
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subgroups), especially for evaluating and promoting
equitable service provision;
￿ identify the minimum volume of activity associated
with the best treatment outcomes;
￿ promote internal and external auditing;
￿ identify critical areas in which to implement pro-
grams that improve health care quality;
￿ monitor trends in health care quality over time.
In order to highlight differences in the performance of
local commissioning authorities, P.Re.Val.E evaluated out-
comes according to patient residence. Importantly, direct
standardization methods [17-20] rather than indirect stan-
dardization methods [5,7,10,20] were used for the com-
parative evaluation of outcomes. The aim of this report is
to describe the P.Re.Val.E. program, including information
sources, statistical methodologies, results for 2006-2009
(published online at http://www.epidemiologia.lazio.it/
vislazio/vis_index.php, and the updated Italian version at
http://www.epidemiologia.lazio.it/prevale10/index.php),
and the impact of releasing performance data to the
public.
Methods
Study design and data sources
We defined 54 performance indicators in different clinical
areas that included treatment for cardiac, cerebrovascular,
orthopedic, obstetric, respiratory, and digestive disorders
[14]. Some were health outcome indicators, such as 30-
day mortality after an episode of myocardial infarction or
30-day complications after cholecystectomy; others were
process indicators for which an association with improved
health outcomes has been already proven, such as inter-
vention within 48 hours of hospital admission for hip frac-
ture in the elderly. Finally, hospitalization rates for
pathologies generally treated out of the hospital, such as
diabetes, asthma, and influenza, were considered an indi-
cation of failure in primary care [21].
Most indicators were selected based on their previous
use in international and national studies [7-19,21-24],
while other indicators were developed in order to describe
particular components of care or clinical pathways. A
rationale and a detailed operative protocol were elaborated
for each indicator according to a standard outline [14].
The indicators were defined using information collected
from regional health information systems covering the
whole Lazio population: the Hospital Information System
(HIS), the Emergency Information System (EIS), the Mor-
tality Information System (MIS), the Report Admission-
Discharge for Rehabilitation (RADR), and the Hospital
Deliveries Information System (HDIS). For detailed infor-
mation about each, please see http://www.epidemiologia.
lazio.it/vislazio_en/fonti.php.
The HIS database was the primary source for case selec-
tion and outcomes/comorbidities data. We also used
information from the EIS database to better identify
comorbidities and to estimate the time to death or time to
surgery after arrival at the hospital (i.e. admission to the
Emergency Department or to a hospital ward). Deaths
during the study period were identified using the HIS, the
EIS, and the MIS. The RADR database was used to iden-
tify admission to a rehabilitation center following hospital
admission for stroke. Finally, we used the HDIS database
for more accurate identification of new births, primary
cesarean deliveries, and risk factors for cesarean section
which are not included in the HIS.
HIS records were linked with EIS, MIS, RADR, and
HDIS records using deterministic record-linkage. To
ensure maximum coverage of the population while avoid-
ing double counting, the linkage method uses a unique
patient identifier deriving from information on persons’
names, date and place of birth and gender, according to
Italian privacy legislation.
Study population
P.Re.Val.E. analyzed hospital discharges in the Lazio region
in the 2006-2009 period [14]. Most data were expressed as
ratios in which the numerator represents the number of
treatments/interventions provided or the number of
patients with a given outcome (i.e., short-term mortality,
hospitalization for specific conditions, etc.) and the
denominator represents the group of patients at risk. In
other cases, the indicators were defined as survival/waiting
time (e.g., the wait for surgery after hip fracture).
The analyses were performed, two years over two
years, by area of residence regardless of the hospital at
which the patient was treated and by hospital.
Definition and attribution of outcome
The outcome measures were as follows: 30-day mortality,
short-term re-hospitalization, hospitalization for specific
conditions, surgical procedures, short-term complications
of specific interventions, and waiting times. The outcomes
under study were attributed to the first emergency depart-
ment at which the patient was treated (first access) or to
the first admission hospital and to the area of residence.
Coexisting medical conditions
Chronic comorbidities and/or severity characteristics that
were potentially associated with the outcomes under
study were chosen using information in the literature
[7-9,17,18,21-23,25-30] and in the Mattoni-Outcome
project [13]. The potential risk factors were identified on
the basis of ICD-9-CM codes registered either during
hospitalization for the condition under study (index hos-
pitalization) or in previous hospital or emergency depart-
ment admissions during the previous two years. Acute
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could be complications of care/treatments (i.e. on the
causal pathway between exposure and outcome), were
not included.
Statistical analysis
Statistical analyses were performed by first admission or
access hospital as well as by area of residence. Since
patient characteristics, such as age, sex, severity of dis-
ease, and/or chronic comorbidities, could be heteroge-
neously distributed across the hospitals/areas of
residence, risk-adjustment methods were applied [31].
The risk adjustment procedure involved construction of
a severity measure (“ap r i o r i ” r i s k )t h a tw a ss p e c i f i cf o r
the study population and the use of this measure to
obtain “adjusted” outcome measures for comparison
between hospitals/areas. The severity measure was calcu-
lated by analyzing the multivariate relationship between
possible outcome predictors and the outcome considered
by application of multivariate regression models (predic-
tive models) including: 1) ap r i o r irisk factors (age, sex,
and/or severity of the condition being investigated); and
2) factors selected by a bootstrap stepwise procedure.
Stepwise analysis was performed with 500 replicated
samples of the original data and significance thresholds
of 0.10 and 0.05 for entry and removal, respectively.
Only risk factors (pre-existing chronic conditions, etc.)
selected in at least 50% of the runs were included in the
final models
We used logistic regression models for dichotomous
outcome variables and survival models for outcomes
expressed in terms of survival times. In order to estimate
adjusted group-specific (hospital/area of residence) log
odds of outcome, logistic regression models with no inter-
cept and centred covariates were applied for each out-
come. Adjusted risks were obtained for each group by
back-transforming parameter estimates with the following
formulas:
Adj risk = [exp(estimate)/(1 + exp(estimate))]*k
where k is a correction coefficient introduced to take
into account the nonlinear nature of the logistic model.
K is calculated as follows:
k =
actual number of events
m 
j=1
pj ∗ nj
where pj are the adjusted risks, nj is the group size,
and m is the number of groups.
This approach allowed comparison of the outcome for
a given facility or area of residence with that of the whole
study population and with each of the other facilities/
areas [18,32,33]. In order to assess for cluster effects, we
used the cluster sandwich ("robust”) variance-covariance
estimators, relaxing the usual requirement that the obser-
vations are independent. According to this methodology,
the observations are independent across groups but not
necessarily within groups.
The adjusted RR estimated for each hospital/area of
residence, the adjusted risk or median waiting time, and
the corresponding p-value were reported on-line in tab-
ular and graphical forms.
For each indicator, trend analyses and comparisons of
the 2008-2009 data versus the 2006-2007 data were
developed by hospital and area of residence.
Variable Life-Adjusted Display (VLAD) charts [34,35]
were constructed to identify the principal increases/
decreases and trend reversals in the cumulative sums of
the differences between the number of events observed
(deaths, rehospitalizations, reoperations, complications,
etc.) and the number expected based on the predictive
model. Two tests of statistical significance were per-
formed, the first to determine whether during the study
period, the number of events observed in one month
(from the second day of the previous month to the first
day of the following month) was significantly different
from the number of expected events and the second to
determine whether the number of observed events
between 2 trend-reversal points was significantly different
from the number of expected events. Both significance
tests were performed using the ratio of observed to
expected events assuming a Poisson distribution.
Finally, since higher activity volumes of the hospitals
are often associated with better outcomes, we also inves-
tigated those relationships (displayed as scatter plots).
The level of statistical significance was set at 5% (p <
0.05), and all analyses were performed using SAS Ver-
sion 8.2 [36].
Preliminary disclosure of performance data to clinicians
and providers
Before public release of data, we shared the P.Re.Val.E
methods and results with different groups of clinicians
and providers, to promote discussion and encourage con-
tributions and critical assessments.
Results
We calculated 54 indicators, 9 of which were prevention
quality indicators, that covered almost 40% of all hospital
admissions in the Lazio Region during the 2008-2009
period. The results obtained for all indicators, available
online at http://www.epidemiologia.lazio.it/prevale10/
index.php, showed a great heterogeneity of the healthcare
quality in the Lazio region.
Public disclosure of the indicators’ results caused
mixed reactions but finally promoted discussion and
refinement of some indicators, e.g., for 30-day mortality
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mates for some indicators and stimulated audit activities
among clinicians and healthcare organizations.
In 2008, Agency for Public Health of Lazio designed a
clinical pathway for elderly patients with hip fracture.
The clinical pathway was tested in five selected hospitals
before the implementation in all Lazio hospitals.
In 2009, a regional health service regulation went into
effect that required Lazio hospitals to adopt the clinical
pathway for elderly patients with hip fracture and that
introduced a compensation system for hospitals based on
quality of healthcare (as in a pay-for-performance model).
The DRG reimbursement rate for Lazio providers was
linked to hospital performance. In fact, from 2009 on, the
full DRG rate has only been paid for patients who under-
went surgical treatment within 48 hours after admission,
while rates for interventions performed after 48 hours
were reduced proportionally based on the time to surgery.
Based on the P.Re.Val.E. experience, the Italian National
Agency for Regional Health Services has launched a
National Outcome Program aimed at systematically com-
paring outcomes in hospitals and local health units in
Italy.
As an example, results pertaining the 30-day mortality
rate after hospital admission for acute myocardial infarc-
tion (AMI) in Lazio region were shown [for the operative
protocol see: additional File 1, Appendix: operative
protocol].
There were 16, 682 AMI episodes in 2008-2009 with a
mean mortality rate of 11.1% (men: 8.9%; women: 15.2%).
The probability of death was 2 times higher when chronic
diseases (liver, pancreas, intestine) in the index admission,
cancer and other cardiac operations were present (Table 1).
The adjusted mortality rates ranged from 6.7% to 19.2% in
different hospitals, and from 8.8% to 13.7% for different
areas of residence (Tables 2 and 3). In the previous 2-year
period there were 17436 AMI episodes, the mean mortality
rate was 12.2%, with high variability among the different
facilities and areas. In general, the adjusted mortality rates
showed a small decrease over time for most facilities and
areas (data not shown). Although the VLAD charts were
developed for each facility and area, the results from two
large hospitals that showed very different time trends for
30-day mortality after AMI admission were reported only.
In 2008-2009, Presidio Ospedaliero Nord, Latina, showed a
greater number of observed deaths after AMI admission
than expected, with a little decrease in November 2009
(Figure 1), whereas San Filippo Neri, Rome, generally had
fewer observed events than expected ones (Figure 2).
Discussion and Conclusions
Comparative evaluation of hospital performance is a use-
ful tool for improving health care quality [1,4]. The U.S.
experience has shown that public disclosure of compara-
tive evaluation results should be managed as one compo-
nent of an integrated quality improvement strategy, and
that the public release of performance data is most effec-
tive at the level of the provider organization [3,4,37]. Reg-
ular feedback seems to increase the accountability of
providers, which are sensitive to public image and poten-
tial legal risks; it can also spur quality improvement activ-
ities in health care organizations, especially when
underperforming areas are identified [38]. However, pro-
viders that are identified as poor performers are more
likely to question the validity of the data, particularly
when the results are first released [39].
Table 1 Acute myocardial infarction: mortality within 30 days of hospital admission, predictive model
Risk Factors N Crude OR Adjusted OR p
Age (years) - 1.08 1.08 0.000
Gender (Females vs Males) 5 767 1.84 1.05 0.419
Cancer 810 2.52 2.05 0.000
Hypertention 3 072 1.52 0.85 0.024
Previous myocardial infarction 2 481 0.96 0.73 0.000
Cardiomyopathy (index admission) 259 0.82 0.63 0.040
Cardiomyopathy 218 1.88 1.14 0.505
Heart failure 1 117 2.77 1.62 0.000
Other heart conditions (index admission) 367 1.06 0.60 0.006
Other heart conditions 228 1.83 1.08 0.688
Cerebrovascular disease 1 122 2.43 1.47 0.000
Vascular disease 679 2.23 1.57 0.000
Chronic renal disease 876 2.82 1.66 0.000
Other chronic disease (liver, pancreas, intestine) (index admission) 105 2.52 2.33 0.001
Other chronic disease (liver, pancreas, intestine) 209 1.98 1.35 0.135
Previous coronary angioplasty 1 417 0.57 0.65 0.000
Other cardiac interventions 127 1.69 2.06 0.006
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hospital care have been undertaken at the national and
regional levels only in the last decade [13,17,40,41]. Based
on these experiences, we developed the Regional Outcome
Evaluation Program, called P.Re.Val.E. [14]. The high
numbers of patients investigated, the accuracy in the selec-
tion of the cohorts and the study outcomes, the consoli-
dated statistical strategy, and the replication of similar
findings for different clinical conditions are important ele-
ments of internal and external validity. For 2006-2009,
results were obtained using direct risk adjustment for
comparative evaluation of outcomes for hospitals and
areas of residence. Hospital league tables obtained by
indirect standardization procedures should not be used for
hospital-to-hospital comparisons [20]. This technique can
lead to biased conclusions unless the distribution of risk
factors or their effects do not vary between the hospitals
being compared.
After receiving comparative reports based on standar-
dized performance measures, hospitals that began as
low-level performers tended to improve faster than
those that started at higher levels of performance [42].
Since studies have shown little correlation between mea-
sured quality of care and Standardized Mortality Ratios
(SMRs) [43,44], we used different outcome and/or process
measures for each studied condition to better identify the
hospitals/geographic areas that needed health care quality
improvement. This study used data from several health
care information systems, and most of the indicators were
based on the concept of first hospital access, correspond-
ing to patient admission to an acute inpatient facility or to
emergency department access. The indicators for which
Table 2 Acute myocardial infarction: mortality within 30 days of hospital admission, by health care facility
Hospital Location N Crude rate × 100 Adjusted rate × 100 Adjusted RR p
OSP. S. CAMILLO DE LELLIS RIETI 509 12.57 12.23 1.10 0.461
OSP. S. SPIRITO ROME 574 10.28 8.43 0.76 0.049
OSP. ANZIO-NETTUNO ANZIO 351 9.69 9.11 0.82 0.269
OSP. ALBANO-GENZANO ALBANO 361 13.02 12.75 1.15 0.366
OSP.S. PAOLO CIVITAVECCHIA 298 14.77 13.86 1.25 0.162
OSP. PARODI DELFINO COLLEFERRO 320 8.75 8.23 0.74 0.129
OSP. S. SEBASTIANO FRASCATI 250 12.80 11.99 1.08 0.675
OSP. S. GIOVANNI EVANG TIVOLI 200 19.50 19.17 1.73 0.001
OSP. GRASSI ROME 648 9.72 9.17 0.83 0.152
OSP. S. EUGENIO ROME 485 13.81 12.25 1.10 0.454
OSP. S.PIETRO F.B.F. ROME 232 12.93 14.02 1.26 0.216
OSP. VANNINI ROME 706 10.62 10.89 0.98 0.874
CC S. ANNA POMEZIA 179 12.29 17.45 1.57 0.034
CC NUOVA ITOR ROME 258 14.73 10.60 0.96 0.792
CC CITTA’ ROMA ROME 203 8.37 6.72 0.61 0.046
CC AURELIA HOSPITAL ROME 396 10.35 10.59 0.95 0.775
PRES. OSP. NORD LATINA 690 11.30 13.49 1.22 0.096
PRES. OSP. SUD FORMIA 500 11.80 13.16 1.19 0.204
CC CITTA’ DI APRILIA APRILIA 245 13.47 13.48 1.22 0.286
OSP. UMBERTO I FROSINONE 556 9.17 10.07 0.91 0.502
OSP. CIVILE ANAGNI 152 9.87 10.98 0.99 0.968
OSP. S.S.TRINITA’ SORA 220 10.91 11.44 1.03 0.885
OSP. G. DE BOSIS CASSINO 222 9.46 8.85 0.80 0.323
OSP. S. PERTINI ROME 763 11.40 11.99 1.08 0.491
OSP. BELCOLLE VITERBO 602 10.96 12.40 1.12 0.386
A.O. S. CAMILLO-FORLANINI ROME 1021 12.83 13.00 1.17 0.088
A.O. S. GIOVANNI ROME 679 7.81 7.52 0.68 0.007
A.O. S.FILIPPO NERI ROME 770 10.91 11.58 1.04 0.708
POLICLINICO A. GEMELLI ROME 695 8.06 7.73 0.70 0.011
POLICLINICO UMBERTO I ROME 557 10.23 11.88 1.07 0.619
A.O. S. ANDREA ROME 615 4.88 6.16 0.55 0.001
A.O. POL. TOR VERGATA ROME 505 5.94 9.67 0.87 0.451
RR: Relative Risk
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tal access provide a measure of the appropriateness and
efficacy of the health care process that begins when a
patient arrives to a given facility. Use of the MIS and EIS
databases, in addition to the HIS database, allowed more
accurate identification of 30-day mortality.
To monitor the time trends of the different outcomes,
we used VLAD charts, a type of quality control chart
that is a good tool for measuring the variability of an
event adjusting for patient risk [34,35,45,46]. VLAD
charts provide an easy-to-understand and up-to-date
view that allows early detection of runs of good or bad
outcomes and thus can prompt timely intervention for
critical situations. The VLAD charts also highlight small
variations over time for observed events compared to
expected events; this information is often obscured by
the corresponding synthetic indicator.
The P.Re.Val.E. results for 2008-2009 [14] provided an
overview of the hospital care heterogeneity in the Lazio
region. The results do not constitute a “league table” of
performance, but instead reveal numerous instances of
high-quality care as well as problem areas that merit
further analysis and internal and external auditing as
part of an increasingly well-developed program of clini-
cal governance.
P.Re.Val.E. is an outcome research program conceived
mainly as a tool for promoting discussion among health-
care managers and professionals in the Lazio region.
Given the complexities of accurately comparing provider
outcomes, we published the methods used for develop-
ing the program in detail, using others’ suggestions for
the public reporting of comparative health outcome eva-
luations [47] so that the face validity of the results could
be evaluated. We also used various tools to present the
Table 3 Acute myocardial infarction: mortality within 30 days of hospital admission, by area of residence
Area N Crude rate × 100 Adjusted rate × 100 Adjusted RR p
Rome District I 385 10.39 9.31 0.84 0.297
Rome District II 312 10.90 8.80 0.79 0.202
Rome District III 129 15.50 12.39 1.12 0.641
Rome District IV 567 9.70 9.04 0.82 0.152
Rome District V 709 10.86 11.13 1.00 0.982
Rome District VI 515 11.65 11.06 1.00 0.981
Rome District VII 298 9.40 9.86 0.89 0.546
Rome District VIII 565 9.03 10.96 0.99 0.932
Rome District IX 351 12.25 10.06 0.91 0.548
Rome District X 454 9.69 10.44 0.94 0.696
Rome District XI 415 14.70 12.49 1.13 0.387
Rome District XII 427 11.94 11.26 1.01 0.922
Rome District XIII 700 11.43 10.92 0.98 0.891
Fiumicino 221 9.50 9.90 0.89 0.620
Rome District XV 445 11.46 10.31 0.93 0.623
Rome District XVI 424 12.97 11.52 1.04 0.794
Rome District XVII 268 13.43 10.19 0.92 0.636
Rome District XVIII 393 12.72 11.46 1.03 0.827
Rome District XIX 594 11.62 10.05 0.91 0.444
Rome District XX 414 11.84 12.84 1.16 0.329
ASL RM/F 894 10.07 10.04 0.90 0.368
ASL RM/G 1278 10.95 11.78 1.06 0.500
ASL RM/H 1693 10.16 10.92 0.98 0.846
Viterbo 182 9.34 8.77 0.79 0.347
Viterbo Province 741 12.42 13.08 1.18 0.132
Rieti 181 9.39 9.37 0.84 0.504
Rieti Province 329 13.37 13.16 1.19 0.281
Latina 307 11.73 12.45 1.12 0.511
Latina Province 1223 11.37 12.73 1.15 0.124
Frosinone 180 11.67 13.71 1.24 0.345
Frosinone Province 1088 9.93 10.62 0.96 0.662
RR: Relative Risk
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cular, we used bar graphs to clearly display adjusted
estimates, as well as tables that included the number of
admissions, the crude and adjusted estimates, and the
statistical significance of the results.
Public disclosure of the 2006-2009 results to clini-
cians, health care managers, and policy makers was
aimed at creating an incentive to improve results. In
fact, studies describing the effect of public reporting on
consumers’ choices, effectiveness, patient safety and
patient-centeredness have shown that the public release
of performance data mainly stimulates change at hospi-
tal level [48]. There have been some negative reactions,
but in most cases, the results have stimulated increased
Figure 1 VLAD chart. Acute myocardial infarction: mortality within 30 days of hospital admission. Hospital Presidio Ospedaliero Nord, Latina.
Figure 2 VLAD chart. Acute myocardial infarction: mortality within 30 days of hospital admission. Hospital S. Filippo Neri, Rome.
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sionals. Clinicians and program developers have met
several times to discuss the methodology as well as
negative findings, such as poor performance or poor
coding accuracy. Physicians have made suggestions
about more accurate selection criteria for some indica-
tors. As a consequence of the extremely low proportion
of interventions for hip fracture in the elderly within 48
hours in most facilities, the regional authority decided
that hospitals with performance results below a given
standard would be penalized economically by a reduc-
tion in fees corresponding to specific Diagnosis Related
Groups (DRGs) [49].
P . R e . V a l . E .i sap r o g r a mi np r o g r e s s ,a n di tw i l lb e
updated and further developed by the definition and cal-
culation of additional indicators, e.g., those aimed at eval-
uating health care quality for oncology patients, and by
the use of regional drug dispensing registries to more
accurately identify patient comorbidities. The impact of
health care performance information disclosure to the
general public should be evaluated. Evidence suggests
that this information has only a limited impact on consu-
mer decision-making [39] since people have limited
access to data on health care providers [50]; however,
studies suggest that people are interested in comparative
information [51,52].
These analyses have explicit limitations, especially with
regard to the marked variability in the coding accuracy of
current health care information systems. This issue is cri-
tical for ensuring accurate risk adjustment, and, corre-
spondingly, reliable comparative quality ratings [53]. In
the past, administrative databases have too frequently
been used exclusively as tools to claim financial reimbur-
sement for services provided without concern for their
roles as epidemiologic sources and as essential instru-
ments for clinical governance. There are some important
advantages to routinely collecting administrative data: it
is inexpensive to do this, and the data provide informa-
tion about large populations, do not depend on voluntary
participation by individual clinicians and providers, and
can be used to predict risk of death with discrimination
comparable with that obtained from clinical databases
[54]. However, the use of routinely collected administra-
tive data in comparative outcome evaluations has been
criticized for the following reasons: there is an absence of
clinical information needed to adequately adjust for
patients’ conditions [55,56]; there is an inability to distin-
guish between a disease present at admission (a comor-
bidity, i.e. a true patient risk factor) and one that
occurred during the hospital stay (i.e. a complication)
[56,57] and some chronic comorbidities, such as hyper-
tension and diabetes, are known to be currently under-
reported at admission, mainly in more severely affected
patients [58,59]. The first problem could be overcome in
the P.Re.Val.E. update for 3 conditions, namely AMI,
aortocoronary bypass, and hip fracture, since some clini-
cal information (e.g., systolic blood pressure, ejection
fraction, creatinine) have been recently added to the HIS
[60]. Moreover, in these 3 conditions, intrinsic illnesses
a tt h et i m eo fp a t i e n t s ’ admissions can be distinguished
from complications since “present on admission” (POA)
flags have been added to discharge diagnoses [61]. The
problem of under-recording is also partially solvable by
using prior patient hospitalization records to identify
comorbidities independent of patient severity at the
current admission [61] as well as emergency department
visits to collect additional information about patient risk
factors. However, the coding accuracy may differ widely
among the facilities [62], and this could lead to biased
comparisons. Even though the possibility of gaming of
t h ed a t ai nr e s p o n s et ot h ep e rformance evaluation can-
not be excluded, previous studies did not find evidence
of gaming [63]. Some studies have reported that changes
in data accuracy may partially explain quality improve-
ment [64]. However, we did not find relevant changes in
recording of co-morbidities in our study population over
the years (data not shown). In agreement with previous
reports, the prevalence of certain co-morbidities and risk
factors was relatively low in our study population, indi-
cating underreporting of co-morbidities and detailed
clinical information in the administrative database [65].
However, underreporting was non-differential in the
years included in our analysis. Moreover, a previous Ita-
lian study [65] assessing clinical performance in cardiac
surgery demonstrated that the use of an administrative
database provided similar league tables as a more com-
plex specialized database.
Finally, since health care services can only be evaluated
by empirical measurements, inevitably there will be errors
(systematic and random). This represents a clear limitation
of our analysis as well as others of this type. We agree with
Shahian et al. that hospital mortality estimates could vary,
sometimes widely, based on the different case-selection
criteria and statistical methods, leading to divergent infer-
ences about relative hospital performance. Despite these
concerns, some findings could be useful to potential users
or to facilities [66]. P.Re.Val.E. openly declares the data
sources and methods, allowing external review of biases
and distortions implicit to the evaluation process. The
next P.Re.Val.E. analysis, expected in November 2011, will
include improvements in methods and procedures; of
course, we cannot say that other biases will not be intro-
duced, simply that they will be different. It is our convic-
tion, however, that P.Re.Val.E. is an important operative
tool that should be used to promote clinical and organiza-
tional monitoring of health care providers, to support poli-
tical decision-making processes, and to stimulate a sense
of healthy, productive competition aimed at improving
Fusco et al. BMC Health Services Research 2012, 12:25
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Page 8 of 10healthcare efficacy and equity. We hope that this program
will encourage a value often neglected within the Italian
NHS: accountability.
Additional material
Additional file 1: Appendix: operative protocol. 30-Day Mortality Rate
after hospital admission for Acute Myocardial Infarction (AMI).
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